PerkinElmer Executive and Leadership Team

Michael Stubblefield, the Chief Executive Officer at PerkinElmer, directs the overarching corporate strategy and global operational vision. By aligning the organization with the evolving needs of the diagnostics and life sciences sectors, the Chief Executive Officer ensures PerkinElmer maintains a competitive edge in complex research environments. Stubblefield manages the integration of advanced technologies across international markets, fostering growth through targeted acquisitions and internal development. This leadership role involves constant collaboration with the Board to refine long-term objectives and maximize shareholder value. By prioritizing scientific excellence and operational efficiency, Michael Stubblefield drives the company toward sustainable market leadership. The Chief Executive Officer monitors performance metrics across all business units, ensuring that every division contributes to the broader mission of solving critical healthcare challenges. Ultimately, Stubblefield secures the future of the enterprise by championing innovation and maintaining rigorous standards of excellence in every scientific endeavor.

Michael Battles, the Chief Financial Officer at PerkinElmer, manages the fiscal health and capital allocation strategies of the organization. Overseeing global financial planning and analysis, the Chief Financial Officer ensures that resources support the core mission of delivering diagnostic and life science solutions. Battles directs the financial reporting processes, maintaining transparency and compliance across all international operations. This leadership role requires close coordination with the executive team to evaluate investment opportunities and optimize the cost structure of the business. By implementing robust financial controls, Michael Battles protects the assets of the company while facilitating expansion into new applied markets. The Chief Financial Officer monitors market trends to mitigate risks and capitalize on growth opportunities within the healthcare sector. Through disciplined fiscal management, Battles provides the stability necessary for the company to pursue ambitious research and development goals, ensuring long-term financial viability and operational success.

Jean-Pierre Ferrando, the Interim Chief Financial Officer at PerkinElmer, executes the financial strategy and maintains the integrity of the accounting functions during this transition period. Overseeing the daily financial operations, the Interim Chief Financial Officer ensures that the company meets its reporting obligations and maintains liquidity. Ferrando manages the balance sheet and cash flow, providing the necessary oversight to support ongoing research and development projects. This leadership role involves working with the finance department to refine budgeting processes and improve cost management across the organization. By providing steady financial guidance, Jean-Pierre Ferrando supports the strategic objectives of the company while ensuring compliance with regulatory standards. The Interim Chief Financial Officer monitors the financial performance of various business segments to identify areas for improvement and efficiency. Through careful analysis and prudent management, Ferrando maintains the financial health of the enterprise, ensuring that the company continues to deliver value to stakeholders and customers alike.

Richard Begley, the President, Emerging Technologies at PerkinElmer, directs the research and development of next-generation solutions that address future scientific challenges. Overseeing the innovation pipeline, the President, Emerging Technologies ensures that the company remains at the forefront of diagnostic and life science advancements. Begley manages the exploration of new technologies that have the potential to disrupt existing markets and create new opportunities for growth. This leadership role involves collaborating with research teams to translate complex scientific concepts into practical, scalable products. By identifying emerging trends, Richard Begley drives the development of cutting-edge tools that empower researchers and clinicians. The President, Emerging Technologies monitors the progress of high-impact projects to ensure they align with the long-term vision of the company. Through strategic investment in innovation, Begley secures the future of the enterprise, ensuring that the company continues to lead the industry in providing solutions for the most critical scientific and healthcare needs.

Jeff Schroeder, the President, Strategic Accounts at PerkinElmer, directs the relationships with the most significant clients and partners of the organization. Overseeing the management of key accounts, the President, Strategic Accounts ensures that the company delivers tailored solutions that meet the specific needs of large-scale research and diagnostic institutions. Schroeder manages the sales and service strategies that drive revenue growth and strengthen long-term partnerships. This leadership role involves coordinating with internal teams to provide comprehensive support and ensure that the company remains the preferred provider for major clients. By focusing on the unique requirements of strategic partners, Jeff Schroeder drives the expansion of the market presence of the company. The President, Strategic Accounts monitors client satisfaction and market feedback to refine the service delivery model and enhance the value proposition. Through proactive engagement and relationship management, Schroeder ensures that the company maintains its position as a trusted leader in the life sciences and applied markets.

Alexey Sosnovskiy, the Senior Vice President, Customer Enablement and Chief of Staff at PerkinElmer, architects the frameworks that improve client engagement and operational efficiency. By streamlining internal processes, the Senior Vice President, Customer Enablement and Chief of Staff ensures that the organization delivers seamless support to researchers and clinicians. Sosnovskiy coordinates cross-functional initiatives that align departmental goals with the broader corporate strategy. This leadership role involves managing complex projects that enhance the customer experience across the life sciences and diagnostics portfolios. By optimizing communication channels and resource allocation, Alexey Sosnovskiy drives productivity and fosters a culture of accountability. The Senior Vice President, Customer Enablement and Chief of Staff monitors service delivery metrics to ensure that the company meets the high standards required by the global scientific community. Through strategic oversight, Sosnovskiy strengthens the connection between internal operations and external market demands, ultimately supporting the growth of the business.

Walter Discenza, the Chief Information Officer & Director, Worldwide IT at PerkinElmer, directs the digital infrastructure and technological capabilities of the enterprise. Overseeing the global IT landscape, the Chief Information Officer & Director, Worldwide IT ensures that data systems remain secure and scalable to support the needs of scientists and clinicians. Discenza manages the implementation of advanced software solutions that facilitate research and diagnostic workflows. This leadership role involves protecting the intellectual property of the company through rigorous cybersecurity protocols and robust network management. By modernizing the digital architecture, Walter Discenza drives operational efficiency and enables data-driven decision-making across all business units. The Chief Information Officer & Director, Worldwide IT collaborates with other executives to integrate new technologies that enhance the competitive position of the company in the life sciences market. Through continuous innovation, Discenza ensures that the technological foundation of the organization remains resilient and capable of supporting future growth.

Kristen Norris, the Chief Human Resources Officer at PerkinElmer, directs the talent acquisition, development, and retention strategies that support the global workforce. Overseeing the organizational culture, the Chief Human Resources Officer ensures that the company attracts top-tier scientific and professional talent to drive innovation. Norris manages the implementation of performance management systems and leadership development programs that align with the mission of the organization. This leadership role involves fostering an inclusive environment that encourages collaboration and professional growth across all regions. By optimizing human capital, Kristen Norris drives the operational success of the company and ensures that the workforce remains agile in the face of market changes. The Chief Human Resources Officer collaborates with the executive team to design compensation and benefits structures that remain competitive in the life sciences industry. Through strategic workforce planning, Norris supports the long-term goals of the enterprise, ensuring that the company possesses the expertise required to solve critical healthcare challenges.